Pharmacokinetics (PK)
Understanding how drugs are absorbed, distributed, metabolized, and eliminated is critical to successful drug development. CenExel’s Pharmacokinetics (PK) research supports sponsors with precise data collection, advanced bioanalytical capabilities, and experienced clinical teams to accelerate informed development decisions across all phases of research.
Studies Conducted
Acute & post-surgical pain focus
0
+
Trial Participants
Enrolled in acute pain studies
0
+
Active Sites
Specialized research locations
0
Overview
Leading Pharmacokinetic Research Excellence
CenExel delivers comprehensive pharmacokinetic research solutions designed to evaluate drug exposure, bioavailability, metabolism, and elimination characteristics. Our experienced teams provide high-quality PK data that supports regulatory submissions and informed clinical development decisions.
From first-in-human studies through late-phase development, we employ rigorous sampling methodologies, advanced analytical techniques, and precise operational execution to ensure reliable and actionable pharmacokinetic outcomes.
Conditions Covered
Pharmacokinetic Studies We Support
Our PK research capabilities support a wide range of therapeutic programs and study designs.
Single Ascending Dose (SAD)
Multiple Ascending Dose (MAD)
Food Effect Studies
Drug-Drug Interaction Studies
Bioavailability Studies
Bioequivalence Studies
Mass Balance Studies
Special Population Studies
Renal Impairment Studies
Hepatic Impairment Studies
Our Approach
Why Sponsors Choose CenExel for PK
Our pharmacokinetics expertise goes beyond sample collection and analysis—we deliver scientific insight, precise bioanalytical execution, and reliable data to support informed development decisions.
01
Advanced Sampling Expertise
Experienced teams execute intensive PK sampling schedules with precision, ensuring accurate concentration-time profile data.
02
Comprehensive Study Designs
Support for SAD, MAD, food effect, interaction, and bioavailability studies across diverse therapeutic areas.
03
High-Quality Data Collection
Rigorous operational procedures ensure reliable pharmacokinetic and pharmacodynamic endpoints.
04
Accelerated Development Decisions
Actionable PK insights help sponsors optimize dosing strategies and advance programs efficiently.
Phase Coverage
Supported Trial Phases
We support pharmacokinetic studies across all phases of development, from first-in-human assessments through post-marketing investigations.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Pharmacokinetics Task Force
CenExel's Pharmacokinetics Task Force brings together clinical pharmacologists, investigators, bioanalytical experts, and operational specialists to support complex PK programs. The team focuses on optimized protocol execution, precise sample collection, and high-quality data generation that enables confident decision-making throughout drug development.
Active Sites
15 Sites
CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas
Also in Pain & Inflammation
